Serina Therapeutics, Inc. (SER): Net Income
-$19.18M
Year ended 2025-12-31
-$21.18M
Trailing 12 months to 2026-06-30
| Period ended | Net Income | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$19.18M | n/m | 2026-03-25, From 2025-01-01 |
| 2024-12-31 | -$11.14M | n/m | 2026-03-25, From 2024-01-01 |
| 2023-12-31 | $5.27M | n/m | 2025-03-24, From 2023-01-01 |
| 2022-12-31 | -$10.46M | n/m | 2024-03-22, From 2022-01-01 |
| 2021-12-31 | -$8.68M | n/m | 2023-03-31, From 2021-01-01 |
| 2020-12-31 | -$10.87M | n/m | 2022-03-29, From 2020-01-01 |
| 2019-12-31 | -$12.15M | n/m | 2021-03-31, From 2019-01-01 |
| 2018-12-31 | -$7.50M | n/m | 2020-03-31, From 2018-01-01 |
| 2017-12-31 | -$6.58M | n/a | 2019-04-01, From 2017-01-01 |
Net Income at similar companies
| Company | Year ended | Net Income | Change YoY |
|---|---|---|---|
| Serina Therapeutics, Inc. (SER) | 2025-12-31 | -$19.18M | n/m |
| BullFrog AI Holdings, Inc. (BFRG) | 2025-12-31 | -$6.50M | n/m |
| iBio, Inc. (IBIO) | 2026-06-30 | -$33.04M | n/m |
| Lisata Therapeutics, Inc. (LSTA) | 2025-12-31 | -$16.59M | n/m |
| Actinium Pharmaceuticals, Inc. (ATNM) | 2025-12-31 | -$33.89M | n/m |
| Clene Inc. (CLNN) | 2025-12-31 | -$26.17M | n/m |
| Silo Pharma, Inc. (SILO) | 2025-12-31 | -$4.23M | n/m |
| Regen BioPharma Inc (RGBP) | 2025-09-30 | -$1.27M | n/m |
| Inovio Pharmaceuticals, Inc. (INO) | 2025-12-31 | -$84.95M | n/m |
Compare SER, BFRG, IBIO, LSTA side by side · Screen every company in Pharmaceutical Preparations ↗